SCHEMBL7607643

SCHEMBL7607643

CCCn1c(=O)[nH]c(=O)c2c1ncn2Cc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 4/20 0.74
ADORA2A P29274 4/20 0.74
PDE4B Q07343 4/20 0.74
PDE4C Q08493 4/20 0.74
PDE4D Q08499 4/20 0.74
BRD4 O60885 7/20 0.73
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
ALDH1A1 P00352 1/20 0.63
BRD2 P25440 2/20 0.62
BRD3 Q15059 2/20 0.62
BRDT Q58F21 2/20 0.62
KDM4E B2RXH2 1/20 0.57
LMNA P02545 1/20 0.57
POLB P06746 1/20 0.57
MAPK1 P28482 1/20 0.57
ADORA2B P29275 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
PDE1A P54750 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3104007 0.93 MEN1 (0.75) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL1713302 0.92 MEN1 (0.70) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL557088 0.91 MEN1 (0.68) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL554932 0.90 BRD4 (0.81) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL556233 0.88 BRD4 (0.82) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL556874 0.88 BRD4 (0.66) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL9504546 0.87 PDE4A (0.66) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL556875 0.87 BRD4 (0.65) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL2795748 0.86 POLB (0.75) PDE4AADORA2APDE4BPDE4CPDE4D
SCHEMBL3902928 0.85 PDE4A (1.00) PDE4AADORA2APDE4BPDE4CPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0812844-B1 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AG (DE) 2002-10-23 EP disclosed
US-6214992-B1 THEOPHYLLINE DERIVATIVES HAVING AT LEAST ONE ETHER FUNCTION IN METHYL RADICAL; XANTHINE COMPOUNDS WITH THIS SUBSTITUTION PATTERN USED AS ANTISHOCK TREATMENT HOECHST AKTIENGESELLSCHAFT (DE) 2001-04-10 US disclosed
EP-0812844-A2 Use of theophyllin derivatives for the treatment and prophylaxis fo shock conditions, novel xanthine compounds and processes for the production thereof HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-17 EP disclosed